Holen Sie sich die Stockscreener-App
140.30
1.53%
2.11
Vorhandelsmarkt:
139.40
-0.90
-0.64%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$138.19
Offen:
$139.08
24-Stunden-Volumen:
933.56K
Relative Volume:
0.98
Marktkapitalisierung:
$6.27B
Einnahmen:
$3.03B
Nettoeinkommen (Verlust:
$237.44M
KGV:
27.89
EPS:
5.03
Netto-Cashflow:
$450.04M
1W Leistung:
+0.75%
1M Leistung:
+5.69%
6M Leistung:
-42.77%
1J Leistung:
-37.05%
1-Tages-Spanne:
$138.14
$141.10
1-Wochen-Bereich:
$135.19
$141.10
52-Wochen-Spanne:
$128.55
$249.91
Teleflex Incorporated Stock (TFX) Company Profile
Firmenname
Teleflex Incorporated
Sektor
Telefon
610-225-6800
Adresse
550 E SWEDESFORD RD, WAYNE, PA
Vergleichen Sie TFX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
140.30 | 6.27B | 3.03B | 237.44M | 450.04M | 5.03 |
|
ISRG
Intuitive Surgical Inc
|
496.36 | 177.83B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
226.04 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.70 | 45.85B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
222.30 | 32.66B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.02 | 17.45B | 17.28B | 108.00M | 391.00M | 0.20 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Herabstufung | Needham | Buy → Hold |
| 2023-05-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-29 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Fortgesetzt | Raymond James | Outperform |
| 2021-07-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Bestätigt | Needham | Buy |
| 2020-11-02 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Wells Fargo | Outperform |
| 2019-04-24 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-02-22 | Bestätigt | Needham | Strong Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-09-10 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-08-03 | Bestätigt | Needham | Buy |
| 2018-05-14 | Bestätigt | Needham | Buy |
| 2018-05-04 | Bestätigt | Needham | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-11-10 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-11-03 | Bestätigt | Needham | Buy |
| 2017-09-08 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Bestätigt | Needham | Buy |
| 2017-03-07 | Eingeleitet | Needham | Buy |
| 2017-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2016-07-12 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Teleflex Incorporated Aktie (TFX) Neueste Nachrichten
Citizens JMP maintains Teleflex stock Market Perform rating - Investing.com
Teleflex gains FDA clearance for new cardiac support device - Investing.com India
FDA OKs Teleflex’s AC3 Range Intra-Aortic Balloon Pump - Medical Product Outsourcing
Teleflex Says FDA Clears AC3 Range Intra-Aortic Balloon Pump - MarketScreener
Prudential Financial Inc. Decreases Stock Holdings in Teleflex Incorporated (NYSE:TFX) - The AM Reporter
Teleflex Receives FDA 510(k) Clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP) - GlobeNewswire
Why Investors Shouldn't Be Surprised By Teleflex Incorporated's (NYSE:TFX) Low P/S - simplywall.st
Teleflex Reports Promising Preliminary Results for Ringer PBC Study - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex - Bluefield Daily Telegraph
Corient Private Wealth LLC Cuts Stake in Teleflex Incorporated (NYSE:TFX) - Defense World
Study Highlights UroLift™ System’s Advantages Over Rezūm™ in Treating BPH - MSN
HighTower Advisors LLC Buys 971 Shares of Teleflex Incorporated (NYSE:TFX) - Defense World
Teleflex reports promising results for coronary perforation management device By Investing.com - Investing.com South Africa
Teleflex reports promising results for coronary perforation management device - Investing.com
Preliminary Results from IDE Study on Ringer™ Perfusion - GlobeNewswire
Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference - Yahoo Finance
Is Teleflex Incorporated (TFX) an Oversold Value Stock to Buy According to Hedge Funds? - Insider Monkey
Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress - GlobeNewswire
Head-to-head study backs Teleflex UroLift system against Boston Scientific’s Rezūm - MassDevice
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex IncorporatedTFX - PrimePublishers.com
Clinical Data: UroLift Achieves 98% Success Rate vs Rezūm in Major BPH Study - StockTitan
Teleflex Core Businesses Healthy but Separation Clouds Near-Term Outlook - Morningstar
What Makes Teleflex Incorporated (TFX) a Cash-Generative Business? - Insider Monkey
Needham & Company LLC Reiterates Hold Rating for Teleflex (NYSE:TFX) - Defense World
Needham maintains hold on Teleflex stock amid growth concerns By Investing.com - Investing.com Canada
Needham maintains hold on Teleflex stock amid growth concerns - Investing.com India
Charles Schwab Investment Management Inc. Increases Holdings in Teleflex Incorporated (NYSE:TFX) - Defense World
AcuityMD Signs 300th MedTech Customer, Teleflex - 01Net
Shareholders that Lost Money on Teleflex Incorporated (TFX) Should Contact Levi & Korsinsky About Securities Fraud InvestigationTFX - ACCESS Newswire
Teleflex’s outlook revised to negative by Moody’s following acquisition and spin-off plans - Investing.com
US Bancorp DE Reduces Stock Position in Teleflex Incorporated (NYSE:TFX) - Defense World
Teleflex Incorporated (NYSE:TFX) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Zacks Research Issues Negative Outlook for Teleflex Earnings - Defense World
Teleflex's (NYSE:TFX) Conservative Accounting Might Explain Soft Earnings - Simply Wall St
Teleflex's (NYSE:TFX) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Teleflex Announces Split Into 2 Public Companies - sharewise
What is Zacks Research’s Estimate for Teleflex Q2 Earnings? - Defense World
TFX LEGAL NOTICE: Teleflex Incorporated Investors are Notified of Pending Securities Fraud Investigation and are Urged to Contact BFA Law - Newsfile
IFP Advisors Inc Buys 217 Shares of Teleflex Incorporated (NYSE:TFX) - Defense World
Morgan Stanley Issues Pessimistic Forecast for Teleflex (NYSE:TFX) Stock Price - Defense World
TFX INVESTOR INVESTIGATION: A Securities Fraud - GlobeNewswire
Teleflex Incorporated Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsTFX - ACCESS Newswire
ATTENTION TFX SHAREHOLDERS: Investors who Lost Money on Teleflex Incorporated are Urged to Contact Levi & Korsinsky about an Ongoing Investigation - ACCESS Newswire
Ex-Dividend Reminder: Constellation Energy, Perrigo and Teleflex - Nasdaq
Morgan Stanley Adjusts Price Target on Teleflex to $191 From $275, Keeps Overweight Rating - Marketscreener.com
Teleflex Incorporated (NYSE:TFX) Shares Sold by Bank of New York Mellon Corp - Defense World
Teleflex cut to Underperform at BofA on spinout concerns - MSN
Teleflex (NYSE:TFX) Downgraded to “Underperform” Rating by Bank of America - Defense World
ATTENTION TFX SHAREHOLDERS: Investors who lost money on Teleflex Incorporated are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire
Finanzdaten der Teleflex Incorporated-Aktie (TFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):